Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes

HUNG-YUAN LIYI-DER JIANGTIEN-JYUN CHANGWei, Jung-NanJung-NanWeiMAO-SHIN LINLin, Cheng-HsinCheng-HsinLinFU-TIEN CHIANGSHYANG-RONG SHIHCHI-SHENG HUNGHua, Cyue-HueiCyue-HueiHuaSmith, David JDavid JSmithVanio, JaniJaniVanioLEE-MING CHUANG2023-02-082023-02-082011-030012-1797https://scholars.lib.ntu.edu.tw/handle/123456789/627751Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the breakdown of amines to produce aldehyde, hydrogen peroxide, and ammonia. Serum VAP-1 correlates positively with both acute hyperglycemia and diabetes. We conducted a cohort study to evaluate whether serum VAP-1 predicts 10-year survival in type 2 diabetic patients.enSENSITIVE AMINE OXIDASE; COLORECTAL-CANCER; P-SELECTIN; INSULIN; BINDING; RISK; OVEREXPRESSION; ADIPOCYTES; VAP-1/SSAO; MELLITUS[SDGs]SDG3Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetesjournal article10.2337/db10-0607212823682-s2.0-79952367891WOS:000288060300034https://api.elsevier.com/content/abstract/scopus_id/79952367891